Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
The American Journal of Cardiology
|
April 3, 2012
Fate of patients with prehospital resuscitation for ST-elevation myocardial infarction and a high rate of early reperfusion therapy (results from the PREMIR [Prehospital Myocardial Infarction Registry])
Oliver Koeth, Lutz Nibbe, Hans-Richard Arntz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
|
September 25, 2020
Establishment of an extracorporeal cardio-pulmonary resuscitation program in Berlin - outcomes of 254 patients with refractory circulatory arrest
Jens Nee, Roland Koerner, Daniel Zickler, et al.
European Heart Journal
|
May 23, 2014
Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial
Uwe Zeymer, Arnoud van 't Hof, Jennifer Adgey, et al.
Recenti Progressi in Medicina
|
February 3, 2017
[Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin.]
Farzin Beygui, Maaret Castren, Natale Daniele Brunetti, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 29, 2015
Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC
Farzin Beygui, Maaret Castren, Natale Daniele Brunetti, et al.
Open Heart
|
December 12, 2017
Early clinical outcomes as a function of use of newer oral P2Y<sub>12</sub> inhibitors versus clopidogrel in the EUROMAX trial
Kurt Huber, Gregory Ducrocq, Christian W Hamm, et al.
American Heart Journal
|
November 26, 2013
Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention
Philippe Gabriel Steg, Arnoud van 't Hof, Peter Clemmensen, et al.
The New England Journal of Medicine
|
November 1, 2013
Bivalirudin started during emergency transport for primary PCI
Philippe Gabriel Steg, Arnoud van 't Hof, Christian W Hamm, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
The American Journal of Cardiology
|
April 3, 2012
Fate of patients with prehospital resuscitation for ST-elevation myocardial infarction and a high rate of early reperfusion therapy (results from the PREMIR [Prehospital Myocardial Infarction Registry])
Oliver Koeth, Lutz Nibbe, Hans-Richard Arntz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
|
September 25, 2020
Establishment of an extracorporeal cardio-pulmonary resuscitation program in Berlin - outcomes of 254 patients with refractory circulatory arrest
Jens Nee, Roland Koerner, Daniel Zickler, et al.
European Heart Journal
|
May 23, 2014
Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial
Uwe Zeymer, Arnoud van 't Hof, Jennifer Adgey, et al.
Recenti Progressi in Medicina
|
February 3, 2017
[Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin.]
Farzin Beygui, Maaret Castren, Natale Daniele Brunetti, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 29, 2015
Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC
Farzin Beygui, Maaret Castren, Natale Daniele Brunetti, et al.
Open Heart
|
December 12, 2017
Early clinical outcomes as a function of use of newer oral P2Y<sub>12</sub> inhibitors versus clopidogrel in the EUROMAX trial
Kurt Huber, Gregory Ducrocq, Christian W Hamm, et al.
American Heart Journal
|
November 26, 2013
Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention
Philippe Gabriel Steg, Arnoud van 't Hof, Peter Clemmensen, et al.
The New England Journal of Medicine
|
November 1, 2013
Bivalirudin started during emergency transport for primary PCI
Philippe Gabriel Steg, Arnoud van 't Hof, Christian W Hamm, et al.
Page
of 2